- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x SKQ: 5-chloranyl-4-(4-cyclohexyl-3-oxidanylidene-piperazin-1-yl)-1~{H}-pyridazin-6-one(Non-covalent)
- 4 x CA: CALCIUM ION(Non-covalent)
CA.2: 5 residues within 4Å:- Chain A: E.417, Q.420, N.435, D.438, R.491
2 PLIP interactions:2 interactions with chain A- Metal complexes: A:E.417, A:D.438
CA.6: 5 residues within 4Å:- Chain B: E.417, Q.420, N.435, D.438, R.491
2 PLIP interactions:2 interactions with chain B- Metal complexes: B:E.417, B:D.438
CA.9: 5 residues within 4Å:- Chain C: E.417, Q.420, N.435, D.438, R.491
2 PLIP interactions:2 interactions with chain C- Metal complexes: C:E.417, C:D.438
CA.12: 5 residues within 4Å:- Chain D: E.417, Q.420, N.435, D.438, R.491
2 PLIP interactions:2 interactions with chain D- Metal complexes: D:E.417, D:D.438
- 4 x LPP: 2-(HEXADECANOYLOXY)-1-[(PHOSPHONOOXY)METHYL]ETHYL HEXADECANOATE(Non-covalent)
LPP.3: 15 residues within 4Å:- Chain A: I.493, L.513, Y.523, R.553, F.565, Q.569, F.572, W.573, S.608, L.613
- Chain D: F.595, A.598, T.599, T.603, V.610
10 PLIP interactions:9 interactions with chain A, 1 interactions with chain D- Hydrophobic interactions: A:I.493, A:L.513, A:Y.523, A:Y.523, A:F.572, A:F.572, A:L.613, D:V.610
- Hydrogen bonds: A:Q.569
- Salt bridges: A:R.553
LPP.4: 15 residues within 4Å:- Chain A: F.595, A.598, T.599, T.603, V.610
- Chain B: I.493, L.513, Y.523, R.553, F.565, Q.569, F.572, W.573, S.608, L.613
10 PLIP interactions:9 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:I.493, B:L.513, B:Y.523, B:Y.523, B:F.572, B:F.572, B:L.613, A:V.610
- Hydrogen bonds: B:Q.569
- Salt bridges: B:R.553
LPP.7: 15 residues within 4Å:- Chain B: F.595, A.598, T.599, T.603, V.610
- Chain C: I.493, L.513, Y.523, R.553, F.565, Q.569, F.572, W.573, S.608, L.613
10 PLIP interactions:1 interactions with chain B, 9 interactions with chain C- Hydrophobic interactions: B:V.610, C:I.493, C:L.513, C:Y.523, C:Y.523, C:F.572, C:F.572, C:L.613
- Hydrogen bonds: C:Q.569
- Salt bridges: C:R.553
LPP.10: 15 residues within 4Å:- Chain C: F.595, A.598, T.599, T.603, V.610
- Chain D: I.493, L.513, Y.523, R.553, F.565, Q.569, F.572, W.573, S.608, L.613
10 PLIP interactions:9 interactions with chain D, 1 interactions with chain C- Hydrophobic interactions: D:I.493, D:L.513, D:Y.523, D:Y.523, D:F.572, D:F.572, D:L.613, C:V.610
- Hydrogen bonds: D:Q.569
- Salt bridges: D:R.553
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vinayagam, D. et al., Structural basis of TRPC4 regulation by calmodulin and pharmacological agents. Elife (2020)
- Release Date
- 2020-12-09
- Peptides
- Transient receptor potential cation channel subfamily c member 4a: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x SKQ: 5-chloranyl-4-(4-cyclohexyl-3-oxidanylidene-piperazin-1-yl)-1~{H}-pyridazin-6-one(Non-covalent)
- 4 x CA: CALCIUM ION(Non-covalent)
- 4 x LPP: 2-(HEXADECANOYLOXY)-1-[(PHOSPHONOOXY)METHYL]ETHYL HEXADECANOATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vinayagam, D. et al., Structural basis of TRPC4 regulation by calmodulin and pharmacological agents. Elife (2020)
- Release Date
- 2020-12-09
- Peptides
- Transient receptor potential cation channel subfamily c member 4a: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.